Michael Ward Email and Phone Number
Michael Ward work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Michael Ward personal email
- Valid
Michael Ward phone numbers
Partner and General Counsel for Benevolent Capital, a private equity investment firm based in New York and Los Angeles focused on creating value by providing necessary capital to strategically chosen companies. Utilizing its own resources and through partnerships with leading institutional investors and sophisticated high net worth contacts, Benevolent Capital invests in profitable, growing, small to mid-market companies with strong business models, histories of revenue and earnings growth and the leadership capable of sustaining that growth.Most recently served as the President & Chief Executive Officer for AEterna Zentaris (NASDAQ: AEZS), a pharmaceutical company based in Charleston, S.C., and with operations in Frankfurt, Germany, where I served as Managing Director. I handled getting our sole drug candidate Macrilen approved both by the FDA and EMA and its out-licensing to Strongbridge BioPharma which sold the rights to Novo Nordisk for over $150 Million.I have also served as General Counsel and Chief Compliance Officer and an executive team member for public and private companies, with a strong history in businesses that are leaders in their industries. I was formerly the Chief Legal & Compliance Officer and Corporate Secretary of a publicly traded company in the generic pharmaceutical industry and handled its sale ($440 Million) to the largest generic pharmaceutical company in Japan.Previously, I served as General Counsel and compliance officer for two large global companies that manufactured and marketed computer accessories and other technology products. I also served in senior legal and executive roles at a Fortune 200 healthcare and pharmaceutical services company for over a decade.In addition to advising boards and management, I apply hands-on skills and experience in: Global Regulatory Compliance Strategic Alliances, Joint Ventures and Strategic Partnering Public Company Legal Management M&A IP Data Privacy IT and Technology Transactions Litigation and Dispute Resolution (EU, North America, Latin America, Singapore and Hong Kong)
Benevolent Capital
View-
General Counsel | PartnerBenevolent Capital Jan 2007 - PresentLos Angeles, UsBenevolent Capital, a private equity investment firm based in New York and Los Angeles is focused on creating value by providing necessary capital to strategically chosen companies. Utilizing its own resources and through partnerships with leading institutional investors and sophisticated high net worth contacts, Benevolent Capital invests in profitable, growing, small to mid-market companies with strong business models, histories of revenue and earnings growth and the leadership capable of sustaining that growth.www.benevolentcapital.com
-
InvestorFlyhouse Sep 2024 - PresentVan Nuys, California, Us -
InvestorLe Petit Béret Jul 2024 - PresentBéziers, Occitanie, Fr -
InvestorChamberlain Coffee Jun 2024 - Present -
InvestorToto Apr 2024 - PresentSanta Monica, Ca, Us -
InvestorBarcode® Performance Water Mar 2024 - PresentLos Angeles, Us -
InvestorPostcard Cabins (Formerly Getaway) Mar 2023 - PresentBrooklyn, Us -
InvestorBest Day Brewing Oct 2022 - PresentSausalito, California, Us -
InvestorCarbon6 Mar 2022 - PresentToronto, Ca -
InvestorYumcrunch Oct 2021 - Present -
InvestorFuture Health Mar 2021 - PresentNew York, New York, Us -
Board Member (2021-2022) And InvestorDamon Motorcycles Sep 2021 - PresentVancouver, British Columbia, Ca -
InvestorAthletic Brewing Co. Jan 2021 - PresentMilford, Ct, Us -
InvestorŌura Dec 2020 - PresentOulu, Northern Ostrobothnia, Fi -
President And Chief Executive OfficerAeterna Zentaris Inc. Jul 2017 - Dec 2019Charleston, South Carolina, UsServed as the President & Chief Executive Officer for AEterna Zentaris (NASDAQ and TSX: AEZS), a pharmaceutical company based in Charleston, S.C., and with operations in Frankfurt, Germany, where I served as Managing Director. I handled getting our sole drug candidate Macrilen approved both by the FDA and EMA and its out-licensing to Strongbridge BioPharma which sold the rights to Novo Nordisk for over $150 Million. Increased market capitalization seven-fold during my tenure from .79 per share to $5.57 per share -
Chief Legal And Compliance Officer & Corporate SecretarySagent Pharmaceuticals Jun 2015 - Oct 2016Schaumburg, Il, UsSpecialty pharmaceutical company (NASDAQ:SGNT) in North America focusing on developing, manufacturing, and marketing injectable pharmaceutical products sold globally with sales over $325 Million. Sagent sells over 110 generic injectable products with an additional 40 products under development, and approximately 70 ANDA’s under FDA review. Chief Legal Officer, Chief Compliance Officer & Corporate SecretaryResponsible for managing a three person legal department with responsibility for all global aspects of legal, compliance, M&A, regulatory and risk management activities for Sagent and its Canadian subsidiary, Omega Laboratories, Ltd. In addition, • Worked closely with Board of Directors, advisors and CEO in handling all aspects of legal and regulatory process in auction process for sale of Sagent in an all-cash merger transaction ($736 Million) to Nichi-Iko Pharmaceutical Co. Ltd.• Handled all aspects of legal and regulatory process in acquisition ($40 Million) by Sagent of five injectable generic products (including Propofol) divested by Teva and Actavis• Developed and implemented several global compliance programs• Responsible for handling and training of all compliance (CMS, export controls, FCPA, OFAC, privacy and Sunshine Act) and public company (Sarbanes-Oxley and SEC) filing and governance matters• Participated in all Board of Directors and committee meetings and prepared all consents, minutes and legal/compliance presentations. • Led investigations into all whistleblower complaints• Responsible for litigation activities, including Paragraph IV matters, SEC investigations and FDA reporting matters• Handle corporate development through in-licensing and product development arrangements• Handled sale of Chinese subsidiary, including a FDA-approved facility, to Nanjing King-Friend Pharmaceutical Co., Ltd.• Responsible for legal due diligence and commercial negotiations with acquisition targets -
Vice President & Assistant General Counsel – Global Compliance, Ethics And LitigationCdk Global, Inc. (Formerly Adp Dealer Services) Sep 2014 - May 2015CDK Global (NYSE:CDK) is the largest global provider of integrated information technology and digital marketing solutions to the automotive retail industry which was spun off from ADP into a separate public company on October 1, 2014.Reported to General Counsel and responsible for all global aspects of compliance and privacy in over 100 countries. Also responsible for ethics, internal investigations, and litigation for global operations. ● Developed and implemented global anti-bribery, antitrust/competition, code of business conduct, export controls, OFAC, privacy, social media and TCPA policies and training materials● Chaired the Anti-Bribery and Policy Governance Committee and co-chaired a global Enterprise Risk Assessment project for an Audit Committee ERM project. Legal committee member for SOX and COSO projects● Created internal global compliance and privacy reporting system, and quarterly reporting materials to the Audit Committee● Handled U.S.- EU Safe Harbor self-certification filing● Handled responses and remediation plans to data breaches under numerous state laws● Supervised over 60 litigation matters ● Appointed Chief Global Privacy Officer
-
Vp & General Counsel, Kensington; Vp, Assoc. Gc, Chief Litigation And Risk Counsel, Acco BrandsAcco Brands Corporation Jul 2007 - Sep 2014Lake Zurich, Illinois, UsACCO Brands (NYSE:ACCO) is one of the world’s largest suppliers of branded office products (Swingline®, Day-Timer®, At-A-Glance,® Five Star®, Quartet®, Kensington®) with operations in over 100 countries. Associate General Counsel, Chief Litigation & Risk Officer, ACCO Brands Corporation 2007 - 2014Responsible for numerous global aspects of governance, risk management, regulatory and antitrust compliance (including Asia, E.U., Latin and North America), and Audit Committee matters (including governance issues, litigation strategy presentations, internal investigations and whistleblower complaints). ● Developed and implemented global anti-bribery, OFAC, EU and Member State privacy, preservation of legal privileges, and antitrust/competition policies and training for employees, suppliers and other third parties● Supervised litigation matters in various courts and international panels within North America, Latin America, and the EU, serving as second chair in most US-based litigation● Developed and implemented global product compliances policies and protocols● Handled internal investigations, Code of Conduct training and annual certification process (1,500 employees), and hotline-based investigations● Led antitrust regulatory approvals and certain third party due diligence (U.S., Brazil and Canada) in merger with office products group of MeadWestvaco Corporation valued at over $900 Million● Coordinated legal support of global dealer and distributor business operations Also served as General Counsel of the Kensington Technology Products Group (Redwood Shores, California) of ACCO Brands. ● Served as second chair for several patent infringement lawsuits● Obtained several global patent infringement litigation recoveries and licensing arrangements in favor of Kensington● Successfully handled patent infringement lawsuit against key competitor which led to acquiring assets of competitor for a fraction of their value -
Senior Vice President, General Counsel & Corporate SecretaryTargus Group International, Inc. Jan 2003 - Jun 2007Anaheim, Ca, Us$545 Million consumer-brand computer luggage and accessories company with operations in over 105 countries.Senior Vice President, General Counsel and Corporate SecretaryFirst in-house lawyer for global company jointly-owned by private equity (SKM/Apax Partners) and founder. Reported to President and responsible for all global compliance, legal, and risk management functions, including product and regulatory compliance. Additionally responsible for worldwide product recalls, regulatory proceedings, internal investigations and anti-bribery and privacy training. Prepared company compliance materials and processes for issuing public debt. Responsible for all corporate secretary duties, including preparation of Board materials and coordination with Board of Directors.● Successfully pursued multiple global legal actions, obtaining judgments, restitution, and settlements totaling over $35 Million in embezzlement, indemnity, and trade secret actions ● Assisted in developing, implementing and operating a procurement business in Asia for product sourcing and distribution operations● Created a legal and compliance department, implementing legal processes, procedures and systems for all global regions covering over 500 employees and approximately 100 suppliers● Led successful recovery actions for multi-million dollar settlements against two Asian suppliers for indemnity actions● Handled product recalls ordered by CPSC, Health Canada, RAPEX and Asian organizations● Favorably resolved over seven lawsuits stemming from $40 Million embezzlement, including a private shareholder lawsuit● Successfully resolved governmental investigations without incurring liability relating to embezzlement and other malfeasance allegations ● Implemented FCPA compliance measures including policies, hotline reporting, risk assessment due diligence of third parties, and training -
Vice President - Corporate DevelopmentAmerisourcebergen Corporation Mar 1991 - Mar 2002Conshohocken, Pa, UsFormerly Bergen Brunswig Corporation. Fortune 35 company ($145 Billion annual revenue) in the medical device and pharmaceutical distribution and services industry (NYSE:ABC).Vice President-Corporate Development, 2000 - 2002Reported to President and responsible for developing and implementing corporate business development strategy; negotiated and structured corporate alliances, licensing arrangements, investment vehicles and partnerships with software, and technology companies. Worked with Wall Street and Silicon Valley firms and private equity to monetize intangible assets.● Developed and managed investment activities, resulting in investment gains in excess of $6 Million, as well as other investment vehicles which led to eight-figure increase in targeted sales● Managed over 15 alliance relationships with suppliers and customers, and assisted in the initial public offering of Omnicell (NASDAQ:OMCL) President & General Manager, MedNet, MPC Corporation (wholly-owned subsidiary of Bergen Brunswig Corporation), Las Vegas, Nevada. 1998 – 2000 Reported to CEO and responsible for executive, regulatory compliance, human resources, and legal matters for national mail-order pharmacy and prescription benefit management operations. Responsible for all business development activities and major customer accounts. Rebuilt and expanded core business and operations of former public company (MMRX:NASDAQ) acquired by Bergen Brunswig from Chapter 11 reorganization. ● Created and implemented new business model as a mail-order pharmacy serving as the back-end operations for public and private internet pharmacy portal companies ● P&L responsibility for a $6 Million annual budget, with overall supervision of approximately 40 employees Director of Legal Affairs, Senior Counsel, 1991-1998 Reported to Chief Legal Officer and responsible for handling acquisitions, antitrust and regulatory compliance, corporate governance, and litigation management. -
Senior AssociateK & R Law Group Apr 1989 - Mar 1991M&A, Securities, and transactional lawyer for premier LA-based health care law firm.
Michael Ward Education Details
-
Case Western Reserve University School Of LawJd -
Albion CollegeHistory And Economics
-
Berkley High School
Frequently Asked Questions about Michael Ward
What company does Michael Ward work for?
Michael Ward works for Benevolent Capital
What is Michael Ward's role at the current company?
Michael Ward's current role is General Counsel at Benevolent Capital & Fortuitous Partners; Former Board Member of Damon Motorcycles.
What is Michael Ward's email address?
Michael Ward's email address is mi****@****ime.net
What is Michael Ward's direct phone number?
Michael Ward's direct phone number is +184790*****
What schools did Michael Ward attend?
Michael Ward attended Case Western Reserve University School Of Law, Albion College, Berkley High School.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial